A substance used to destroy pests of the phylum Mollusca.
| Member | Definition | Class |
|---|
| aminocarb | A carbamate ester that is phenyl methylcarbamate substituted by a dimethylamino group at position 4 and a methyl group at position 3. | aminocarb |
| chloroxylenol | A member of the class of phenols that is 3,5-xylenol which is substituted at position 4 by chlorine. It is bactericidal against most Gram-positive bacteria but less effective against Staphylococci and Gram-negative bacteria, and often inactive against Pseudomonas species. It is ineffective against bacterial spores. | 4-chloro-3,5-dimethylphenol |
| cuprous chloride | An inorganic chloride of copper in which the metal is in the +1 oxidation state. | copper(I) chloride |
| cypermethrin | A carboxylic ester resulting from the formal condensation between 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid and the alcoholic hydroxy group of hydroxy(3-phenoxyphenyl)acetonitrile. | cypermethrin |
| dioncophylline a | An isoquinoline alkaloid that is the biaryl resulting from substitution of the hydrogen at the 7-position of (1R,3R)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol by a 4,5-dimethoxy-2-methylnaphthalen-1-yl group. It is a naphthylisoquinoline alkaloid isolated from the roots and stem barks of Triphyophyllum peltatum and exhibits antifungal, antimalarial, antineoplastic and molluscicidal activites. | 7-epi-dioncophylline A; dioncophylline A |
| metaldehyde | A member of the class of tetroxocanes that is 1,3,5,7-tetroxocane which carries four methyl groups at positions 2,4,6 and 8. It is a potent molluscicide and the active ingredient in most slug pellets used for crop protection. | metaldehyde |
| methiocarb | A carbamate ester obtained by the formal condensation of the phenolic group of 3,5-dimethyl-4-(methylsulfanyl)phenol with the carboxy group of methylcarbamic acid. | methiocarb |
| niclosamide | A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections. | niclosamide |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| 67.9K protein | Vaccinia virus | Potency | 1.5954 | 2 | 2 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 10.6108 | 4 | 8 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 25.9313 | 1 | 3 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 24.1654 | 1 | 4 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 1.4137 | 1 | 3 |
| AR protein | Homo sapiens (human) | Potency | 20.7524 | 10 | 21 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 11.7892 | 3 | 6 |
| arylsulfatase A | Homo sapiens (human) | Potency | 37.9330 | 1 | 1 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 0.8792 | 3 | 3 |
| Ataxin-2 | Homo sapiens (human) | Potency | 5.4728 | 1 | 2 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 5.4728 | 1 | 2 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 0.9528 | 1 | 1 |
| atrial natriuretic peptide receptor 2 precursor | Homo sapiens (human) | Potency | 1.3092 | 1 | 1 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 19.9526 | 2 | 2 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 6.4129 | 3 | 8 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 2.6224 | 2 | 6 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 5.6234 | 1 | 1 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 5.6234 | 1 | 1 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 22.9833 | 2 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 70.7946 | 1 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 15.8114 | 1 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 6.3146 | 1 | 2 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 0.3981 | 1 | 1 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 1.5714 | 1 | 2 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 10.5375 | 1 | 4 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 13.4504 | 1 | 1 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 15.3334 | 2 | 8 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 16.0130 | 1 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 0.9750 | 1 | 2 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 0.3445 | 2 | 2 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 2.0749 | 1 | 1 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 89.1251 | 1 | 1 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 69.6219 | 1 | 2 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 59.9763 | 1 | 2 |
| endonuclease IV | Escherichia coli | Potency | 11.2202 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 16.4223 | 10 | 22 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 15.0115 | 2 | 3 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 14.1147 | 10 | 25 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 15.5290 | 1 | 3 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 8.9734 | 4 | 4 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 11.3087 | 4 | 6 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 4.2284 | 1 | 1 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 3.2468 | 1 | 2 |
| G | Vesicular stomatitis virus | Potency | 10.5375 | 1 | 4 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| GALC protein | Homo sapiens (human) | Potency | 0.3162 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 15.3334 | 1 | 4 |
| geminin | Homo sapiens (human) | Potency | 1.0315 | 4 | 8 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 8.4720 | 2 | 10 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 1.5849 | 1 | 1 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 6.8264 | 4 | 5 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 35.1398 | 1 | 5 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 1.9953 | 1 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Homo sapiens (human) | Potency | 1.8493 | 1 | 1 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 30.6421 | 2 | 5 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 1.2182 | 2 | 8 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 0.7360 | 2 | 4 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 70.2680 | 2 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 10.5375 | 1 | 4 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 0.7943 | 1 | 1 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 61.6448 | 1 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 2.2536 | 2 | 4 |
| IDH1 | Homo sapiens (human) | Potency | 14.7296 | 1 | 2 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 10.5375 | 1 | 8 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 3.4173 | 1 | 3 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 3.4173 | 1 | 3 |
| Interferon beta | Homo sapiens (human) | Potency | 10.5375 | 1 | 4 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 2.1178 | 2 | 5 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 0.3762 | 1 | 2 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 15.1114 | 4 | 6 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 79.4328 | 1 | 1 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 5.1209 | 1 | 2 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 0.5012 | 1 | 1 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 3.5406 | 2 | 2 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 3.5481 | 1 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 0.0524 | 1 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 23.2235 | 3 | 10 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 29.0929 | 1 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 61.6146 | 1 | 1 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 7.4989 | 2 | 6 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 25.0267 | 3 | 13 |
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Potency | 3.1623 | 1 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 50.3834 | 1 | 2 |
| Parkin | Homo sapiens (human) | Potency | 1.6326 | 1 | 2 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 9.3233 | 2 | 2 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 0.3793 | 1 | 1 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 1.1884 | 2 | 3 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 3.4974 | 4 | 6 |
| PINK1 | Homo sapiens (human) | Potency | 1.6326 | 1 | 2 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 3.5481 | 1 | 1 |
| polyprotein | Zika virus | Potency | 3.2468 | 1 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 0.1585 | 1 | 1 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 30.2974 | 2 | 8 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 49.4892 | 1 | 2 |
| progesterone receptor | Homo sapiens (human) | Potency | 21.6049 | 1 | 5 |
| pyruvate kinase | Leishmania mexicana mexicana | Potency | 2.5119 | 2 | 2 |
| pyruvate kinase PKM isoform b | Homo sapiens (human) | Potency | 3.1623 | 2 | 2 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 79.4328 | 1 | 1 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 24.6778 | 2 | 6 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 0.0897 | 1 | 2 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 16.8336 | 1 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 0.0566 | 3 | 6 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 14.8162 | 4 | 7 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 1.6208 | 2 | 2 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 1.4972 | 2 | 4 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 1.4972 | 2 | 4 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 0.5209 | 2 | 2 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 10.7748 | 1 | 3 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 0.8913 | 1 | 1 |
| TDP1 protein | Homo sapiens (human) | Potency | 3.3309 | 2 | 8 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 0.0053 | 1 | 1 |
| Thrombopoietin | Homo sapiens (human) | Potency | 0.1000 | 2 | 2 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 20.7388 | 2 | 7 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 1.4125 | 1 | 1 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 25.4228 | 4 | 6 |
| TSHR protein | Homo sapiens (human) | Potency | 92.5374 | 2 | 3 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 3.5481 | 1 | 1 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 3.5481 | 1 | 1 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 59.6649 | 1 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 50.7992 | 2 | 4 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 5.0442 | 4 | 7 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 35.1398 | 1 | 5 |